Duopharma Biotech emerges into digital technology to provide Smarter Solution for a Healthier Life for all
Empowering Naluri’s Digital Health Platform constitutes another milestone in Duopharma Biotech’s innovation strategy
Duopharma Biotech together with Permodalan Nasional Berhad contribute Ventilators for a Government Hospital;
Three Patient Monitoring Devices, which will be used at the Intensive Care Unit (“ICU”) at Government Hospitals
RM10,000 cash was donated to Orang Asli through Epic Society
RM50,000.00 cash was channeled to Government-Linked Companies’ Disaster Response Network (“GDRN”) to purchase other supplies
KUALA LUMPUR, 13 February 2020 – In an announcement to Bursa Malaysia this evening,
Duopharma Biotech Berhad (formerly known as CCM Duopharma Biotech Berhad) (“Duopharma
Biotech” or “Company”) announced a commendable set of unaudited financial results to close off a
strong performance in 2019 with yearly net profit increasing 16 percent to touch RM55.27 million
(2018: RM47.64 million) on higher revenue of RM576.46 million (2018: RM498.72 million).